Abstract
Background: It has been suggested that sarcoidosis patients, especially those on immunosuppressive medications, are at increased risk for COVID-19 infection and more severe disease. Methods: A questionnaire was developed in four languages (English, Dutch, Italian, and Spanish). The questionnaire queried whether patients had been infected with COVID-19 and outcome of the infection. Risk factors for COVID-19 infection were collected. Results: A total of 5200 sarcoidosis patients completed the questionnaire with 116 (2.23%) reporting infection and 18 (15.8%) required hospitalization. Increased hazard ratio (HR) for COVID-19 infection were seen for those with a COVID-19 infected roommate (HR=27.44, p
Original language | English |
---|---|
Article number | 2020009 |
Number of pages | 12 |
Journal | Sarcoidosis Vasculitis and Diffuse Lung Diseases |
Volume | 37 |
Issue number | 4 |
DOIs | |
Publication status | Published - 2020 |
Keywords
- COVID-19
- sarcoidosis
- immunosuppression